Aclaris Therapeutics Inc.
Organization details
- Legal name
- Aclaris Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Wayne
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ACRS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001557746
- EIN
- 46-0571712
Board of directors
-
Anand Mehra · DirectorSince 2023
-
Andrew Kenneth William Powell · DirectorSince 2023
-
Andrew N. Schiff · DirectorSince 2023
-
Bryan M. Reasons · DirectorSince 2023
-
Christopher P. Molineaux · DirectorSince 2023
-
Douglas J. Manion · Director · Pres and CEOSince 2023
-
Hugh M. Davis · Director · President and COOSince 2024
-
Maxine Gowen · DirectorSince 2023
-
Neal Walker · Director · CEOSince 2023
-
Vincent Milano · DirectorSince 2023
-
William D. Humphries · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.4%
Board connections
4 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
Aldeyra Therapeutics Inc. Same sectorvia Neal Walker
-
BioCryst Pharmaceuticals Inc. Same sectorvia Vincent Milano
-
Monte Rosa Therapeutics Inc. Same sectorvia Andrew N. Schiff
-
Passage Bio Inc. Same sectorvia Maxine Gowen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,359,000
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 1, 2026 | Kolbeck Roland Wilhelm Officer (Chief Scientific Officer) | Option exercise | +36,375 | — | — |
| Aug 1, 2026 | Kolbeck Roland Wilhelm Officer (Chief Scientific Officer) | Shares withheld for tax | −12,385 | $5.20 | $64,402 |
| Jun 5, 2026 | Andrew N. Schiff Director | Option exercise | +11,580 | — | — |
| Jun 5, 2026 | Christopher P. Molineaux Director | Option exercise | +11,580 | — | — |
| Jun 5, 2026 | Vincent Milano Director | Option exercise | +11,580 | — | — |
| Jun 5, 2026 | Anand Mehra Director | Option exercise | +11,580 | — | — |
| Jun 5, 2026 | William D. Humphries Director | Option exercise | +11,580 | — | — |
| Jun 5, 2026 | Maxine Gowen Director | Option exercise | +11,580 | — | — |
| May 1, 2026 | Hall Jesse Wayne Officer (Chief Medical Officer) | Option exercise | +36,375 | — | — |
| May 1, 2026 | Hall Jesse Wayne Officer (Chief Medical Officer) | Shares withheld for tax | −9,330 | $4.41 | $41,145 |
| Apr 23, 2026 | Leonard Braden Michael 10% owner | Open-market sale | −300,000 | $4.53 | $1,359,000 |
| Mar 1, 2026 | Balthaser Kevin Officer (Chief Financial Officer) | Option exercise | +2,375 | — | — |
| Mar 1, 2026 | Balthaser Kevin Officer (Chief Financial Officer) | Shares withheld for tax | −677 | $2.87 | $1,943 |
| Feb 3, 2026 | Loerop James Officer (Chief Business Officer) | Option exercise | +20,875 | — | — |
| Feb 3, 2026 | Neal Walker Director, Officer (CEO) | Option exercise | +63,475 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Aclaris Therapeutics Inc.
Who is the CEO of Aclaris Therapeutics Inc.?
Douglas J. Manion is Aclaris Therapeutics Inc.'s Pres and CEO.
How many directors are on Aclaris Therapeutics Inc.'s board?
Aclaris Therapeutics Inc.'s board has 11 directors: Anand Mehra, Andrew Kenneth William Powell, Andrew N. Schiff, Bryan M. Reasons, Christopher P. Molineaux, Douglas J. Manion, Hugh M. Davis, Maxine Gowen, Neal Walker, Vincent Milano and 1 other.
Are Aclaris Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Aclaris Therapeutics Inc. insiders made no open-market purchases and sold $1.4 million of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="aclaris-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.